Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Endra Life Sciences receives patent from European Patent Office » 08:46
08/24/22
08/24
08:46
08/24/22
08:46
NDRA

Endra Life Sciences

/

+

Endra announced that the…

Endra announced that the European Patent Office has issued European Patent No. 3730041 to Endra titled "System for Estimating Fractional Fat Content of an Object." The '041 patent protects ENDRA's TAEUS system for the calculation of fat concentration in the human body with multiple thermoacoustic measurements. The '041 patent is related to U.S. patent 9980677B1 and Chinese patent ZL201880050042.

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Hot Stocks
Endra Life Sciences issued three patents from USPTO » 08:11
08/02/22
08/02
08:11
08/02/22
08:11
NDRA

Endra Life Sciences

/

+

Endra Life Sciences…

Endra Life Sciences announced that the United States Patent & Trademark Office has issued three new patents to Endra including U.S. Patent No. 11379343, U.S. Patent No. 11392479 and U.S. Patent No. 11405470. All three patents are titled "Methods and Systems for Exchange of Equipment Performance Data." These three newly issued patents are part of a patent family that protects Endra's proprietary method and system for acquiring, analyzing and sharing data in the cloud. The '343 and '479 patents protect Endra's data sharing capabilities that are specific to the medical imaging industry. The '470 patent builds upon the company's U.S. Patent No. 11314617. Both the '470 and '617 patents have claims that are narrower than the '343 and '479 patents and apply to industries outside of medical imaging. The '470 patent broadens Endra's coverage from devices "not having internet connectivity" to devices that are "communicatively insulated."

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Hot Stocks
Endra awarded two additional Chinese patents for TAEUS System » 08:03
07/11/22
07/11
08:03
07/11/22
08:03
NDRA

Endra Life Sciences

/

+

ENDRA Life Sciences…

ENDRA Life Sciences announces that the Chinese National Intellectual Property Administration has issued two new patents to ENDRA, Chinese Patent No. ZL 2020 8 00151255 titled "Systems and Methods for Thermoacoustic Transducer Optimization" and Chinese Patent No. ZL 2020 8 00151433 titled "Method and System for Reconstructing a Thermoacoustic Image." "We are delighted to announce our 14th and 15th issued patents in China, which provide intellectual property protection through 2040. These patents demonstrate our commitment to protecting the novel technology used in our TAEUS System in Asia's largest healthcare market with an estimated 350 million people affected by NAFLD-NASH," stated ENDRA's Chairman and Chief Executive Officer Francois Michelon. "Our global intellectual property portfolio has increased to 50 issued patents as we expand protection of our core technology in priority global markets."

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Over a quarter ago
Hot Stocks
Endra Life Sciences enhances TAEUS System intellectual property portfolio » 08:08
06/28/22
06/28
08:08
06/28/22
08:08
NDRA

Endra Life Sciences

/

+

ENDRA Life Sciences…

ENDRA Life Sciences announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 titled "Broadband Applicator for Thermoacoustic Signal Generation." The '272 patent protects TAEUS' radiofrequency applicator for optimizing the delivery of RF energy to tissue. Notably, the RF applicator utilizes a broad bandwidth, which reduces TAEUS' sensitivity to tissue variation and temperature. The '272 patent will serve as the parent patent for future patent applications prosecuted in China and Europe. "We are pleased with the issuance of our 28th patent in the United States, which supports our strategy to develop optimized thermoacoustic imaging systems, and to broaden the potential applications for our proprietary TAEUS technology in areas with unmet clinical needs," stated ENDRA's Chairman and Chief Executive Officer Francois Michelon. "We continue to strengthen our intellectual property portfolio to protect our novel technology in key global markets. Our IP portfolio currently includes 48 patents issued globally."

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Hot Stocks
Endra Life Sciences bolsters TAEUS System intellectual property with US patent » 08:17
05/25/22
05/25
08:17
05/25/22
08:17
NDRA

Endra Life Sciences

/

+

ENDRA Life Sciences…

ENDRA Life Sciences announces that the United States Patent & Trademark Office has issued a new patent to ENDRA, U.S. Patent No. 11337676 titled "Acoustically Compatible Radio-frequency Applicator Method and System." The '676 patent protects ENDRA's method and system for optimizing the delivery of radiofrequency energy to tissue using TAEUS, and serves as the parent patent for applications being prosecuted in China and in Europe. "This issued patent is our 27th in the United States and supports our strategy to develop optimized hybrid ultrasound and thermoacoustic imaging systems and to broaden the potential applications for our proprietary TAEUS technology in areas with unmet clinical needs," stated ENDRA's Chairman and Chief Executive Officer Francois Michelon. "We continue to enhance our intellectual property portfolio to protect our technology in priority global markets. Our IP portfolio currently stands at 90 assets, including 47 patents issued globally."

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Hot Stocks
Endra Life Sciences issued additional patents for TAEUS System » 08:13
05/10/22
05/10
08:13
05/10/22
08:13
NDRA

Endra Life Sciences

/

+

ENDRA Life…

ENDRA Life Sciencesannounces the issuance of four new patents, two in the U.S. and two in China. ENDRA's intellectual property portfolio now includes 90 assets, including 46 issued patents worldwide providing protection for the TAEUS system with its novel hybrid ultrasound and thermoacoustic imaging technology. One of the newly issued U.S. patents, which protects the ability to transfer data without an internet connection, expands potential licensing opportunities for the company. The following four patents, strengthening the TAEUS system's proprietary position, were issued: U.S. Patent No. 11314617, titled "Methods and Systems for Exchange of Equipment Performance Data," is ENDRA's first patent that protects its proprietary method and system for acquiring, analyzing, and sharing data in the cloud. Although this technology was developed for the TAEUS system, it has broad applicability within the healthcare industry and as such, represents an additional licensing opportunity. The company has filed another application to complement the '617 patent, which is expected to form the keystone of a patent family. U.S. Patent No. 11304606, titled "Method and System for Enhancing RF Energy Delivery During Thermoacoustic Imaging," relates to optimizing the thermoacoustic energy source, a radiofrequency emitter, to provide a stronger and clearer signal that improves thermoacoustic measurements. Chinese Patent No. ZL 2019 8 00868104, titled "Method and System for Monitoring Tissue Temperature," relates to a novel method and system for monitoring tissue temperature during surgical procedures. ENDRA expects its TAEUS system to be effective for both thermotherapy and cryotherapy procedures. The '104 patent is linked to its parent, U.S. Patent No. 10631734B1. Chinese Patent No. ZL 2019 8 00859567, titled "Method and System for Estimating Fractional Fat Content of an Object of Interest," relates to a novel method for determining the fractional fat content of an object, such as a person's liver. This method utilizes a radiofrequency applicator that is a critical component of the TAEUS system. The '567 patent is linked to its parent, U.S. Patent No. 11051699B2.

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Syndicate
Endra Life Sciences raises $8.7M in at-the-market facility sale » 08:41
04/21/22
04/21
08:41
04/21/22
08:41
NDRA

Endra Life Sciences

/

+

ENDRA Life Sciences…

ENDRA Life Sciences announces that the company has raised $8.7 million in gross proceeds year-to-date from the sale of common stock through its at-the-market equity facility. Pursuant to its ATM equity offering sales agreement with Ascendiant Capital Markets LLC, the company sold approximately 20.6 million shares of common stock at an average price of $0.42 per share.

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

NDRA Endra Life Sciences
/

+

04/07/22 H.C. Wainwright
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright
Recommendations
Endra Life Sciences price target lowered to $5 from $6 at H.C. Wainwright » 06:15
04/07/22
04/07
06:15
04/07/22
06:15
NDRA

Endra Life Sciences

/

+

H.C. Wainwright analyst…

H.C. Wainwright analyst Vernon Bernardino lowered the firm's price target on Endra Life Sciences to $5 from $6 and keeps a Buy rating on the shares. While it appears Taeus U.S. commercialization will take a while longer, further updates on the pathway in the U.S. are potential positive catalysts, Bernardino tells investors in a research note.

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

Hot Stocks
Endra strengthens TAEUS IP protection with patent issuances in China » 09:26
03/30/22
03/30
09:26
03/30/22
09:26
NDRA

Endra Life Sciences

/

+

ENDRA Life Sciences…

ENDRA Life Sciences announces that the Chinese National Intellectual Property Administration has issued ENDRA two new patents, Chinese Patent No. ZL 2019 8 00400927, titled "Method and System for Determining Fractional Fat Content of Tissue," and Chinese Patent No. ZL 2019 8 00870250 titled "Radio Frequency Applicator and Thermoacoustic Imaging System Employing the Same". "Having recently announced our first research partnership in China with the renowned Shanghai General Hospital, we are keen to bolster our intellectual property protection in Asia's largest healthcare market. We now have 11 patents issued in China supporting our strategy to develop thermoacoustic imaging systems and broadening the application for our proprietary TAEUS technology in areas with unmet clinical needs," stated ENDRA's Chairman and Chief Executive Officer Francois Michelon. "We continue to enhance our intellectual property portfolio to protect our technology in priority global markets. Our portfolio currently stands at 89 assets, which we define as patents issued, filed or in preparation." The '927 patent covers a method and system for determining fractional fat content of tissue that takes into consideration the speed of sound in that tissue. This patent builds upon ENDRA's growing number of issued patents in the area of tissue fat quantification. Conventional ultrasound image formation methodologies assume a single speed of sound, while the '927 patent leverages TAEUS' inherent sensitivity to fractional fat differences in tissue to estimate the actual speed of sound in tissue, and thereby improves the accuracy of TAEUS fat quantification methodologies. The patent also describes a calibration methodology for fractional fat measurements. The '927 patent is linked to its parent, U.S. patent No. 10258277B2. The '250 patent provides more robust intellectual property protection for the TAEUS platform related to its disruptive scanning approach. It covers a radio frequency applicator device and system for providing reliable RF energy to a target area of tissue. More specifically, the '250 patent structurally defines ENDRA's innovative solution to providing targeted RF energy to tissue regions for applications, such as fat quantification of a patient's liver. The '250 patent is linked to its parent, U.S. patent No. 10682059B1.

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

Hot Stocks
Endra Life Sciences says USPTO issues '314 patent' for methods and systems » 08:32
03/08/22
03/08
08:32
03/08/22
08:32
NDRA

Endra Life Sciences

/

+

ENDRA Life Science…

ENDRA Life Science announces that the United States Patent and Trademark Office has issued ENDRA a new patent, U.S. Patent No. 11266314 titled "Method and System for Determining a Material Type of an Object of Interest." The '314 patent protects ENDRA's method and system for determining a material type by utilizing TAEUS. The patent has potential applications beyond liver measurements and even outside the human body. In addition, the '314 patent serves as the parent patent for current patent applications being prosecuted in both China and Europe. "This newly issued patent, our 24th in the U.S., supports our strategy to protect ENDRA's intellectual property, lead innovation in the thermoacoustic sector and broaden the potential applications for our proprietary TAEUS(R) technology for both clinical and non-clinical applications," stated ENDRA's Chief Executive Officer Francois Michelon. "We maintain a concerted effort to enhance the defensive and offensive value of our patent portfolio in priority markets. Our global intellectual property portfolio currently stands at 89 assets, which we define as patents in preparation, filed or issued."

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.